Direct towards the patient and the market: the Open Innovation Lab for Bioengineering is an IBEC initiative promoting market-oriented research activities by providing co-working lab and office space to help high-potential initiatives funded by external investment capital to go further and faster to the market.
The Open Innovation Lab hosts research units with a clear objective to reach the market as soon as possible and take advantage of IBEC’s rich environment of knowledge and science provided by its research groups, its high-tech facilities, national and international networks, and strategic alliances with hospitals and capital and industrial partners.
The initiative is open to companies and investors interested in setting up a new research and development unit with a clear market objective. The research unit is financed by a company or an investor and is allocated in IBEC’s facilities. The goal is to build an ecosystem in bioengineering that empowers entrepreneurial scientists to grow quickly, while maximizing capital efficiency.
IBEC’s initiative is based on a new wave of ‘innovative ecosystems’ being pioneered at Princeton and in Norway, to name just two, and is one of the most important initiatives of IBEC’s new Strategic Plan. It’s fully aligned with our mission to foster innovation, collaboration and entrepreneurship by supporting early stage high-potential projects and bringing our basic and applied research results more quickly to the market.
If you are interested in knowing more, please contact the Technology Transfer Office at TechTransfer@ibecbarcelona.eu .
Bioengineering for Reproductive Health
The first Open Innovation Lab research unit at IBEC will be Bioengineering for Reproductive Health, led by Dr. Samuel Ojosnegros, with four years of financing to the tune of €1.4m from Scranton Enterprises B.V., an investment association based in the Netherlands.
The unit will develop a new system for assisted reproduction programmes to predict the success rate of embryos for implantation. Selecting embryos is a critical aspect of this treatment that at the moment is left largely to chance, leading to disappointment and suffering for many patients.